Background: Effective auscultations are often hard to implement in isolation wards. To date, little is known about the characteristics of pulmonary auscultation in novel coronavirus (COVID-19) pneumonia. Objectives: The aim of this study was to explore the features and clinical significance of pulmonary auscultation in COVID-19 pneumonia using an electronic stethoscope in isolation wards. Methods: This cross-sectional, observational study was conducted among patients with laboratory-confirmed COVID-19 at Wuhan Red-Cross Hospital during the period from January 27, 2020, to February 12, 2020. Standard auscultation with an electronic stethoscope was performed and electronic recordings of breath sounds were analyzed. Results: Fifty-seven patients with average age of 60.6 years were enrolled. The most common symptoms were cough (73.7%) during auscultation. Most cases had bilateral lesions (96.4%) such as multiple ground-glass opacities (69.1%) and fibrous stripes (21.8%). High-quality auscultation recordings (98.8%) were obtained, and coarse breath sounds, wheezes, coarse crackles, fine crackles, and Velcro crackles were identified. Most cases had normal breath sounds in upper lungs, but the proportions of abnormal breath sounds increased in the basal fields where Velcro crackles were more commonly identified at the posterior chest. The presence of fine and coarse crackles detected 33/39 patients with ground-glass opacities (sensitivity 84.6% and specificity 12.5%) and 8/9 patients with consolidation (sensitivity 88.9% and specificity 15.2%), while the presence of Velcro crackles identified 16/39 patients with ground-glass opacities (sensitivity 41% and specificity 81.3%). Conclusions: The abnormal breath sounds in COVID-19 pneumonia had some consistent distributive characteristics and to some extent correlated with the radiologic features. Such evidence suggests that electronic auscultation is useful to aid diagnosis and timely management of the disease. Further studies are indicated to validate the accuracy and potential clinical benefit of auscultation in detecting pulmonary abnormalities in COVID-19 infection.

1.
Wang
C
,
Horby
PW
,
Hayden
FG
,
Gao
GF
.
A novel coronavirus outbreak of global health concern
.
Lancet
.
2020
;
395
(
10223
):
470
3
. .
2.
Zhu
N
,
Zhang
D
,
Wang
W
,
Li
X
,
Yang
B
,
Song
J
, et al.
A novel coronavirus from patients with pneumonia in China, 2019
.
N Engl J Med
.
2020
;
382
(
8
):
727
33
.
3.
Huang
C
,
Wang
Y
,
Li
X
,
Ren
L
,
Zhao
J
,
Hu
Y
, et al.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
.
Lancet
.
2020
;
395
(
10223
):
497
506
. .
4.
Kevat
AC
,
Kalirajah
A
,
Roseby
R
.
Digital stethoscopes compared to standard auscultation for detecting abnormal paediatric breath sounds
.
Eur J Pediatr
.
2017
;
176
(
7
):
989
92
. .
5.
WHO
.
Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance
.
2020 Jan 28
. Available from: https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.
6.
Mikami
R
,
Murao
M
,
Cugell
DW
,
Chretien
J
,
Cole
P
,
Meier-Sydow
J
, et al.
International symposium on lung sounds. Synopsis of proceedings
.
Chest
.
1987
;
92
(
2
):
342
5
. .
7.
Forgacs
P
.
Crackles and wheezes
.
Lancet
.
1967
;
2
(
7508
):
203
5
. .
8.
Ohshimo
S
,
Sadamori
T
,
Tanigawa
K
.
Innovation in analysis of respiratory sounds
.
Ann Intern Med
.
2016
;
164
(
9
):
638
9
. .
9.
Sgalla
G
,
Walsh
SLF
,
Sverzellati
N
,
Fletcher
S
,
Cerri
S
,
Dimitrov
B
, et al.
“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
.
BMC Pulm Med
.
2018
;
18
(
1
):
103
. .
10.
Wan
X
.
Clinical diagnostics
.
Beijing
:
Peoples Medical Publishing House
;
2017
.
11.
Li
Q
,
Guan
X
,
Wu
P
,
Wang
X
,
Zhou
L
,
Tong
Y
, et al.
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
.
N Engl J Med
.
2020
;
382
(
13
):
1199
207
.
12.
Chan
JF
,
Yuan
S
,
Kok
KH
,
To
KK
,
Chu
H
,
Yang
J
, et al.
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
.
Lancet
.
2020
;
395
(
10223
):
514
23
. .
13.
Kui
L
,
Fang
YY
,
Deng
Y
,
Liu
W
,
Wang
MF
,
Ma
JP
, et al.
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
.
Chin Med J
.
2020
;
133
(
9
):
1025
31
.
14.
Chen
N
,
Zhou
M
,
Dong
X
,
Qu
J
,
Gong
F
,
Han
Y
, et al.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
.
Lancet
.
2020
;
395
(
10223
):
507
13
. .
15.
Pan
Y
,
Guan
H
,
Zhou
S
,
Wang
Y
,
Li
Q
,
Zhu
T
, et al.
Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China
.
Eur Radiol
.
2020
;
30
(
6
):
3306
9
.
16.
Bohadana
A
,
Izbicki
G
,
Kraman
SS
.
Fundamentals of lung auscultation
.
N Engl J Med
.
2014
;
370
(
21
):
2053
. .
17.
Tourtier
JP
,
Libert
N
,
Clapson
P
,
Tazarourte
K
,
Borne
M
,
Grasser
L
, et al.
Auscultation in flight: comparison of conventional and electronic stethoscopes
.
Air Med J
.
2011
;
30
(
3
):
158
60
. .
18.
Pan
F
,
Ye
T
,
Sun
P
,
Gui
S
,
Liang
B
,
Li
L
, et al.
Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia
.
Radiology
.
2020
;
295
(
3
):
715
21
.
19.
Pasterkamp
H
,
Brand
PL
,
Everard
M
,
Garcia-Marcos
L
,
Melbye
H
,
Priftis
KN
.
Towards the standardisation of lung sound nomenclature
.
Eur Respir J
.
2016
;
47
(
3
):
724
32
. .
20.
Venkataraman
T
,
Frieman
MB
.
The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis
.
Antiviral Res
.
2017
;
143
:
142
50
. .
21.
Aviles-Solis
JC
,
Jacome
C
,
Davidsen
A
,
Einarsen
R
,
Vanbelle
S
,
Pasterkamp
H
, et al.
Prevalence and clinical associations of wheezes and crackles in the general population: the Tromso study
.
BMC Pulm Med
.
2019
;
19
(
1
):
173
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.